Medicinal Mushrooms: What the Evidence Shows

What the research on medicinal mushrooms covers

Medicinal or functional mushrooms are species people take for what they may do for the body, usually as a powder, extract, tea or capsule. The human research on them is real but thin. Most trials are small and short, and each one tests a single preparation. So a result belongs to the product and amount that study used, and it says little about a different capsule on the shelf.

Lion's mane shows the pattern clearly. In a 2009 placebo-controlled trial of 30 adults with mild cognitive impairment, scores improved during supplementation and faded in the four weeks after it stopped. A 2025 study of a standardized extract then found no significant effect on overall cognition or mood, which leaves the lion's mane trials promising in places and mixed overall.

Reishi has more trials and weaker support for the claims sold with it. A Cochrane review found that randomized evidence does not support reishi for cardiovascular risk factors. Most of what holds up in the reishi research is narrow: changes in immune markers and fatigue scores in limited groups of people.

If you already take a mushroom product, start with its side effects and its possible drug interactions, since those pages deal with harm to you now. If you are still deciding, the preparation and label sections below come next, and the condition pages tell you what a given health claim actually rests on.

Which health claims hold up in human trials?

The condition pages sort each claim by how close the research gets to the outcome you care about. On cholesterol, a review of nine randomized trials found no significant overall effect on total cholesterol, LDL or HDL, while four of five trials that measured triglycerides reported a drop. For heart health, mushrooms fit a heart-conscious diet, but no study has shown that they prevent cardiac events or work like heart medicine. When a randomized trial added mushrooms to a Mediterranean-style diet, blood pressure and blood lipids came out no different.

The weight-loss figures come from meals. When people ate a mushroom lunch matched for volume, the meal carried 339 calories against 783 for beef, and over the next four days they ate back only 11.4 percent of the calories they had saved. The weight loss evidence comes from swapping mushrooms for red meat in ordinary meals, and capsules are a separate and weaker claim.

Several popular claims came up short once researchers tested them. Cordyceps did not improve endurance in a five-week placebo-controlled trial in 22 trained cyclists, and the athletic performance trials show no dependable rise in VO2 max.

The only randomized arthritis trial gave reishi with a second herbal preparation to people with rheumatoid arthritis. It missed its primary outcome, 15 percent against 9.1 percent on placebo, and inflammatory markers did not change. In the one menopause trial, a four-week lion's mane study, no overall measure differed significantly from placebo.

Other claims have never reached a human trial. The reishi claim for hair growth goes back to a 2006 laboratory study in which isolated triterpenoids blocked an enzyme. No controlled human trial has shown that a mushroom supplement regrows hair.

On skin health, the best-documented effect is harm. Eating shiitake raw or undercooked can cause shiitake flagellate dermatitis, an itchy rash in streaks.

Cancer support needs the most care. PSK comes from turkey tail, and a network meta-analysis of 23 randomized trials with 10,684 people with gastrointestinal cancers reported survival signals when doctors added it to standard treatment. Even so, the US Food and Drug Administration has not approved turkey tail or PSK to treat cancer or any other condition. No study has shown that a retail mushroom supplement treats cancer.

Headlines about mushrooms and anxiety usually come from psilocybin, given in a supervised crossover trial of 51 people with life-threatening cancer. Those sessions do not transfer to retail supplements or home use, and psilocybin effects outside a clinical protocol carry their own risks.

For brain health, food studies such as a Singapore cohort linked eating more mushrooms with lower odds of mild cognitive impairment. That kind of study finds an association and cannot show cause. New or worsening memory problems have many possible causes that a doctor can check, and they need that evaluation before any supplement test.

How the preparation changes what you take

Mushroom cell walls rest largely on chitin, which human digestion cannot break. The compounds researchers study stay locked inside until heat or a solvent pulls them out, and each solvent pulls out different ones. Hot water carries the beta-glucans, while the triterpenes in reishi need an alcohol stage. So a powder or extract from the same species can hold quite different compounds.

Label figures add a second trap. Total polysaccharide and beta-glucan are separate measurements that need a specific assay, and total polysaccharide also counts grain starch. That lets a powder of mycelium grown on grain print a high polysaccharide figure while it holds little beta-glucan.

Home preparations follow the same chemistry. Mushroom tea works as a long, lidded simmer, and even then the water carries only the soluble polysaccharides. Drinking alcohol in a mushroom tincture draws out compounds that water carries poorly. Only lab testing can show how much a home batch contains.

No universal dose exists for any of these forms. Reishi trials alone used daily amounts from 200 to 11,200 milligrams over one to 24 weeks, and the review that pooled them rated its evidence very low certainty. Each trial amount fits the species, part, preparation and people in that one study. It tells you nothing about the right amount of the product you hold.

How do you judge a mushroom supplement label?

In the US, dietary supplements reach the market without the premarket approval that medicines need, and the maker carries responsibility for safety and truthful labels. The FDA's good manufacturing practice rules cover whether a company consistently meets its own specifications. They say nothing about whether the product works.

Identity is the first thing to confirm, because it fails more often than buyers expect. A DNA-barcoding study of 33 commercial fungal samples found five labeled with the wrong Latin name. The page on how to choose a mushroom supplement follows the named fungal material through processing to a lab report that matches your batch.

Certification programs such as NSF check label claims and contaminants like toxic elements, microbes and pesticides. Their seal can back up identity and the declared amount. Only clinical research can show that the product does anything for your goal.

Side effects, interactions and when to get help

Digestive upset is the reaction people report most often after medicinal mushroom products. The serious risks are rarer and tied to particular species and forms, so the product, the amount and how long you have taken it shape what a symptom may mean.

Reishi has a small record of liver injury. LiverTox treats it as a rare possible cause, but one reported case of fatal fulminant hepatitis followed reishi powder. No randomized human trial shows that a mushroom product treats liver disease either.

Chaga is unusually high in oxalate. In one reported case, a man who took chaga powder daily for years developed irreversible end-stage renal disease. Another case report describes kidney injury after six months of daily chaga powder. Case reports cannot show how common this is, but the harm in them was severe.

Medicines raise a second set of questions. The Memorial Sloan Kettering reishi monograph flags bleeding risk with warfarin and a conflict with immunosuppressants. Cordyceps has a reported case of heavy bleeding after a dentist pulled a tooth. It also shows glucose-lowering signals in preclinical work that could add to the effect of diabetes medicines.

Stop the product and contact a clinician if you notice dark urine, yellow skin or eyes, or belly pain, or less urine, swelling or flank pain. Swelling of the face or tongue, or trouble breathing, can signal anaphylaxis, which is an emergency: call 911 or your local emergency number.